Hence, this model with the involvement of both insulin resistance and obvious β-cell dysfunction in the development of diabetes could be suitable for studying the pathophysiology of type 2 diabetes as well as for testing new compounds, which act through ameliorating insulin resistance and/or by increasing β-cell insulin secretion [27]. The gene discussed is INS; the disease is diabetes mellitus.